Agata Villiger-Oberbek

Agata Villiger-Oberbek has a diverse work experience in the biotechnology industry. Agata is currently serving as the Head of External Operations and Clinical Supply Chain at Codiak BioSciences since March 2022. In this role, they are responsible for overseeing end-to-end clinical supply operations, managing CMO contracts, and onboarding new vendors. Agata is also involved in forecasting, scheduling manufacturing campaigns, and ensuring timely supply of investigational products for Phase I/II trials. Their role at Codiak also includes managing budgets, working closely with CFO and accounting, and participating in CMC strategic planning and risk assessments.

Before joining Codiak BioSciences, Agata worked at Sanofi from 2011 to 2016. Agata held the position of Staff Scientist and was involved in commercial cell culture development. Agata played a key role in the development of chemically-defined cell culture media formulations to optimize productivity and reduce manufacturing costs. Agata led successful media optimization studies to increase cell specific productivities and titer improvement for a test mAb. Agata also contributed to media powder dissolution and manufacturability studies for large-scale production.

Prior to Sanofi, Agata worked at EPFL as a PhD student and research assistant from 2006 to 2010. Their research focused on the design and development of a method for rapid generation of stable manufacturing CHO cell lines using lentiviral vectors. Agata successfully identified stable, high-expressing clones in just 2 days post-gene delivery.

Agata's earlier experiences include an internship at the Nencki Institute of Experimental Biology, where they worked in the Laboratory of Transcription Regulation. Agata also had an internship at the University of Central Lancashire, where they conducted research in neuro-endocrino-oncology.

Overall, Agata Villiger-Oberbek has a strong background in supply chain management, manufacturing operations, media optimization, and cell line development in the biotechnology industry.

Agata Villiger-Oberbek has an extensive education history in the field of biology and biotechnology. Agata obtained their BSc in Biology from the University of Warsaw in 2003. Following that, they pursued further studies and earned their MSc in Biology from the same university between 2003 and 2005. In 2003, they also attended the University of Central Lancashire, where they studied Biological Sciences. Agata Villiger-Oberbek continued their academic journey by completing a PhD in Biotechnology and Bioengineering from EPFL (École polytechnique fédérale de Lausanne) from 2006 to 2010.